List view / Grid view

German Consortium for Translational Cancer Research (DKTK)



CRISPR technology inactivates cancer mutations

1 September 2016 | By Niamh Louise Marriott, Digital Content Producer

CRISPR/Cas9 is likely one of the most revolutionary tools in biotechnology, with tremendous implications for a broad range of biological and medical disciplines. As programmable scissors this technology allows cleavage of DNA at predefined sites in the genome of cells...